BioMarin to Participate in Upcoming Investor Conferences
SAN RAFAEL, Calif., Nov. 4, 2026
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
BioMarin to Participate in Upcoming Investor Conferences
PR Newswire
SAN RAFAEL, Calif., Nov. 4, 2026
- Stifel Healthcare Conference, November 11 at 3:20 pm EST
- UBS Global Biopharma Conference, November 16 at 9:20 am GMT
- Jefferies Global Healthcare Conference, November 17 at 11:30 am GMT
SAN RAFAEL, Calif., Nov. 4, 2026 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at upcoming investor conferences in November.
An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.
About BioMarin
BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit www.biomarin.com.
|
Contacts: |
|
|
Investors |
Media |
|
Traci McCarty |
Marni Kottle |
|
BioMarin Pharmaceutical Inc. |
BioMarin Pharmaceutical Inc. |
|
(415) 455-7558 |
(650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-upcoming-investor-conferences-302928633.html
SOURCE BioMarin Pharmaceutical Inc.
